Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

Share Price is delayed by 15 minutes
Get Live Data
4.68    0.03 (0.65%)
Bid:
4.63
Ask:
4.685
Spread: 0.055 (1.188%)
Market Cap: £224.62m
SEE Live PriceLast checked at - London Stock Exchange

Intraday Seeing Machines Share Chart

Annual Financial Report

23 Sep 2009 07:00

RNS Number : 5020Z
Seeing Machines Limited
23 September 2009
 

23 September 2009

Seeing Machines Limited

FINAL RESULTS FOR THE YEAR ENDED 30 JUNE 2009

Seeing Machines Limited (AIM: SEE), a leading developer of advanced computer based imaging software systems, announces final results for the year ended 30 June 2009.

Financial Highlights

Revenue increased by A$826,024 to A$5,225,771 (2008: A$4,399,747);

Other income increased to A$304,575 (2008: A$271,975), helped by favourable foreign exchange movements;

Gross profit increased by A$425,108 to A$3,051,569 (2008: 2,626,461); and 

Net loss of A$5,609,112 (2008: Profit A$326,744principally due to a one off write down of intangible assets of A$5,043,984.

Operational Highlights

Marketing of DSS in the global commercial transport and mining sectors;

Release of the first commercial version of faceAPI in August 2008 with sales of over A$250,000;

Release of faceLAB® 5 in February 2009;

Continued progress towards commercialization of the TrueField Analyzer®; and

Restructure of the business in February 2009 to focus on cash generative operations and to conserve cash reserves.

Nick CerneazCEOstated. "The second half of the year saw the business adversely affected by the global economic crisis particularly its impact on our DSS and faceLAB businesses. In light of this the Company was restructured in February 2009 to align its revenue and cost base to preserve cash and focus on cash generating operations. We started seeing signs of recovery in the last quarter and believe the Company is well placed to record positive operational performance going forward following the write down of the intangible assets."

The Seeing Machines Annual Report for 2008-2009 is available for download from the Company's website www.seeingmachines.com and will be posted to shareholders in October 2009. Extracts from the Annual Report are set out below.

Enquiries: 

Seeing Machines Limited

www.seeingmachines.com

Nick Cerneaz, CEO

+61 (0) 2 6103 4700

Grant Thornton Corporate Finance (Nomad)

Fiona Owen / Robert Beenstock

+44 (0) 20 7383 5100

Daniel Stewart & Company plc 

Martin Lampshire

+44 (0) 20 7776 6550

Walbrook PR Ltd

Ben Knowles

Helen Westaway

+44 (0) 20 7933 8780
Mob. +44 (0) 7900 346 978
ben.knowles@walbrookpr.com
helen.westaway@walbrookpr.com

DIRECTORS REPORT (extract)

Review of Operations

Financial Results

Total revenue for the year increased by A$826,024 to A$5,225,771 (2008: A$4,399,747) whilst revenue from sale of goods and license fees was A$4,824,535 (2008: A$3,880,726). Rendering of services (contract) income of A$96,661 (2008: A$247,046) is down due to Seeing Machines involvement in the AutoCRC project being largely completed and on-going work with Hella KGaA Hueck & Co on hold due to the global economic crisis and its impact on the automotive industry. Other income was A$304,575 (2008: A$271,975) up largely due to favourable foreign exchange movements on sales and purchases.

Operational expenditure for the year was A$5,790,899 up by A$1,717,896 on the prior year (A$4,073,003). Total expenses were A$10,834,883 due to a one-off write-down of intangible assets of A$5,043,984. The increase in operational expenditure was due primarily to increased marketing costs including the costs of goods sold commensurate with the higher revenue from sale of goods and the full year costs of the US sales office.

The Company made an operational loss of A$565,128 for the year ended 30 June 2009 a worsening over the prior year where a profit of A$326,444 was recorded. The Company is reporting a net loss of A$5,609,112 for the year ended 30 June 2009. This result is principally due to the write-down of intangible assets totalling A$5,043,984. The operational loss was due largely to lower than expected revenue in the DSS and faceLAB® businesses which were adversely impacted by the global economic crisis and in particular the slow-down in the automotive industry and in the case of faceLAB® a reduced amount of funding available for R&D projects.

The Company had A$679,166 in cash at 30 June 2009 compared to A$2,771,247 at 30 June 2008. Net assets reduced to A$1,593,783 at 30 June 2009 compared to A$7,090,437 at 30 June 2008 This reduction is largely due to the write-down of assets of A$5,043,984 and the reduction in cash reserves.

Although total revenue increased year on year the growth in revenue was adversely impacted by the global economic crisis leading to lower than expected revenue in a number of business segments. A corporate restructure announced in February was undertaken to address some of these adverse impacts. Furthermore the directors believe that the write-down in the value of intangible assets is appropriate given the current uncertain economic times A significant benefit of this write-down is that it provides the Company with a foundation for recording positive operational performance in future years.

Operational Highlights

Highlights for the year ended 30 June 2009 included:

the continued efforts to market the DSS in the global commercial transport and mining sectors;

the development of new analytical tools for the DSS which provide fleet managers with deeper insight into issues of driver drowsiness and distraction within their;

the release of faceLAB® 5 in February 2009;

the release of the first commercial version of faceAPI in August 2008;

the continued progress towards commercialization of the TrueField Analyzer®; and

the relocation of the Company from the Australian National University campus to more suitable commercial premises in Braddon.

Driver State Solution (DSS)

The DSS achieved revenue of A$2,224,810 (2008: A$1,429,793). Although up by A$795,017 (56%) over the prior year this revenue growth was slower than management had anticipated due primarily to the effects of the global economic crisis and the impacts on the automotive industry and the United States economy in particular.

The downturn in the automotive industry saw a pause in our work with Hella KGaA Hueck & Co and progress on the OEM version of the DSS as automotive OEM's cutback on capital expenditure. We are seeing the first signs that this work may get back on track during the coming year.

The weakness in the US economy has also adversely impacted the take-up of the DSS in the US in the prime target markets of commercial fleets and mining operations as companies have been reluctant to make the capital expenditure required for the DSS. Again we are just starting to see the signs that things may improve in 2010 notably in the mining industry, though continued global economic weakness may impact the timing of that. During the last part of the financial year we sold systems to organisations in Indonesia, Botswana, Mexico and Italy and we have also seen strong interest from Australia, the US and South America where there are very significant mining operations in a number of countries including Brazil, Chile and Peru.

The Company has focused ongoing DSS development work on improved data analysis and reporting tools and integration of the systems into customer's operations.  This includes the integration of the DSS with the telemetry, communications and real-time reporting systems of multiple fleet management system vendors particularly for road transport and mine management operations. The changes made to the product throughout the year have continued to mature the DSS from its origins as a sensor of the driver's state (circa 2007) to an integrated solution for managing fatigue in fleet operations, particularly in road transport and mining operations. The new modes of driver alerts and the use of telematics technologies to alert fleet dispatchers of critical situations is particularly relevant to the risk mitigation efforts of all transport fleet managers. The system has also been independently certified according to various applicable electrical and safety standards. 

The focus during 2010 will be to:

secure DSS sales opportunities in private fleets and mining operations, with emphasis on converting the existing portfolio of pilot deployments, to significantly grow the DSS revenue and customer base;

increase our DSS sales force in targeted verticals;

appoint strategic partners and distributors to service particular geographic regions and verticals that are difficult for the Company to pursue directly for reasons including language, cultural and geographic constraints, for example;

continue to develop the product so that it remains the leading fatigue solution in its target markets; and

be ready to move back into the OEM space when the opportunity arises.

faceLAB®

faceLAB® achieved sales of A$2,377,689, slightly down on the prior record year which saw sales in excess of A$2.5 million. Like the DSS, faceLAB® sales were adversely impacted by the global financial crisis with many potential sales being lost at the last minute due to funding being delayed or curtailed. During the last quarter of the year there were signs that this was turning around with a reduced rate of potential sales being lost in this fashion.

faceLAB® 4.6 was released in August 2008. This version included link precision functionality which allows multiple versions of faceLAB® to be linked together in precision mode.

In February 2009 faceLAB® version 5 was released. Key features of this release include:

Multiple screen calibration - gaze intersections for each screen can be calibrated independently;

Screen calibration is possible from faceLAB®, WorldView and any third-party application using the Remoting Software Developer's Kit (SDK);

Full remote control over a network connection with a private SDK to provide selected third-party developers access to these controls;

Lip and eyebrow tracking;

Support for Windows Vista.

Also coinciding with the release of faceLAB® version 5 was the debut of EyeWorks a new rich visual analysis tool from US company Eye Tracking Inc and which is sold under an exclusive arrangement as the analysis suite for faceLAB®. This provides us with a real point of distinction in the growing on-screen analysis market.

faceAPI™

Seeing Machines released the first commercial version of the faceAPI product in August 2008 and sales in excess of a quarter of a million dollars were achieved in the first year of release. Developer licences have been sold to companies developing applications across a broad spectrum of fields including:

3D displays;

Video games;

Augmented reality;

Interactive advertising;

Teleconferencing; 

Virtual worlds;

Robotics; and

Human computer interaction.

The strategy with faceAPI is to derive revenues through two streams:

developer license sales; and

production license sales.

Developers need to acquire production licenses before they are able to distribute their applications to customers.

TrueField Analyzer®

The Company has progressed the development work required to bring the TrueField Analyzer® (TFA) to market and we are aiming to launch the product this year. At the date of this report there remains however a number of unresolved issues that must be addressed before launching the TFA for commercial sale and consequently there exists a possibility that its introduction may be delayed. We are aiming to have those matters resolved allowing the release of the TFA at the next major industry meeting in October 2009.

During the year the TFA has been exhibited at many relevant industry conferences to build awareness and accelerate the update of the product following its launch. Such events included: Veterans' of Foreign Wars (VFW) Meeting in Orlando FL (August 2008), American Academy of Ophthalmology (AAO) Annual Meeting in Atlanta GA (November 2008), Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Ft Lauderdale FL (May 2009), and the World Glaucoma Congress (WGC) in Boston MA (July 2009).

Through the year a number of academic journal papers have been prepared by our research colleagues at the Australian National University (the first has been accepted for publication at the date of this report). A series of academic conference presentations have been made at relevant industry meetings (ARVO, AAO and WGC) and have been well received, including a presentation at the AAO annual meeting (Nov 2008) delivered by the technology's inventor that earned a "Best Paper" award at the meeting.

Initial uptake of the TFA following its launch will be encouraged through support for independent luminary clinical evaluation and then subsequently commercialized through partnership or technology licensing to one of the large medical device OEMs.

James Fulton Muir Nick Cerneaz

Chairman Chief Executive Officer and Director

Balance Sheet

As at 30 June 2009

Consolidated

Parent

2009

2008

2009

2008

Note

A$

A$

A$

A$

ASSETS

Current Assets

Cash and cash equivalents 

12

679,166

2,771,247

648,371

2,765,564

Trade and other receivables 

13

748,550

866,949

1,242,479

872,458

Inventories

14

259,728

288,243

249,225

288,243

Derivative financial instruments 

15

-

12,297

-

12,297

Other current assets

44,972

77,611

44,972

77,611

Total Current Assets

1,732,416

4,016,347

2,185,047

4,016,173

Non-current Assets

Investments in subsidiaries

16

-

-

174

174

Property, plant and equipment 

17

302,549

259,906

300,733

259,906

Intangible assets

18

417,361

357,307

417,361

357,307

Capitalised development costs

18

-

5,849,250

-

5,849,250

Total Non-current Assets

719,910

6,466,463

718,268

6,466,637

TOTAL ASSETS

2,452,326

10,482,810

2,903,315

10,482,810

LIABILITIES

Current Liabilities

Trade and other payables

19

606,370

830,285

598,806

830,285

Provisions

20

232,571

223,353

219,574

223,353

Total Current Liabilities

838,941

1,053,638

818,380

1,053,638

Non-Current Liabilities

Provisions

21

73,602

117,717

73,602

117,717

Government grants

22

-

2,221,018

-

2,221,018

Total Non-Current Liabilities

73,602

2,338,735

73,602

2,338,735

TOTAL LIABILITIES

912,543

3,392,373

891,982

3,392,373

NET ASSETS

1,539,783

7,090,437

2,011,333

7,090,437

EQUITY

Contributed equity

23

9,646,776

9,646,776

9,646,776

9,646,776

Accumulated losses

24

(8,887,593)

(3,278,481)

(8,373,775)

(3,278,481)

Reserves

24

780,600

722,142

738,332

722,142

TOTAL EQUITY

1,539,783

7,090,437

2,011,333

7,090,437

The above balance sheet should be read in conjunction with the accompanying notes.

Income Statement

For the year ended 30 June 2009

Consolidated

Parent

2009

2008

2009

2008

Note

A$

A$

A$

A$

Continuing operations

Sale of goods and license fees

4,824,535

3,880,726

4,824,535

3,880,726

Rendering of services

96,661

247,046

96,661

247,046

Revenue

4,921,196

4,127,772

4,921,196

4,127,772

Cost of sales

(1,869,627)

(1,501,311)

(2,045,658)

(1,501,311)

Gross Profit

3,051,569

2,626,461

2,875,538

2,626,461

Other Income

7

304,575

271,975

304,575

271,975

Deferred Grant income - net off against impairment

2,245,642

-

2,245,642

-

Marketing expenses

(2,190,407)

(705,407)

(1,560,424)

(705,407)

Occupancy and facility expenses

(498,958)

(344,171)

(491,360)

(344,171)

Administrative expenses

(1,222,774)

(1,466,384)

(1,170,506)

(1,466,384)

Impairment of development costs

(7,289,626)

-

(7,289,626)

-

Other expenses

8

(9,133)

(55,730)

(9,133)

(55,730)

Profit (Loss) before income tax

(5,609,112)

326,744

(5,095,294)

326,744

Income tax expense

9

-

-

-

-

Net Profit (Loss) for the year

(5,609,112)

326,744

(5,095,294)

326,744

Cents

Cents

Earnings per share for profit attributable to the ordinary equity holders of the company:

11

Basic earnings per share

(1.906)

0.111

Diluted earnings per share

(1.906)

0.111

The above income statement should be read in conjunction with the accompanying notes.

Statement of changes in equity

For the year ended 30 June 2009

Consolidated

Foreign

Employee

Cash flow

Contributed

Accumulated

Currency

Equity

hedge

Total

Note

Equity

Losses

Translation

reserve

reserve

Equity

A$

A$

A$

A$

A$

A$

At 1 July 2007

6,553,932

(3,605,225)

-

679,722

-

3,628,429

Profit/(Loss) for the year

24

-

326,744

-

-

-

326,744

Total Income and Expenditure for the year

-

326,744

-

-

-

326,744

Share Issue

23

3,199,282

-

-

-

-

3,199,282

Transaction costs

23

(106,438)

-

-

-

-

(106,438)

Share based payments

24

-

-

-

30,123

-

30,123

Net gain on cash flow hedges

24

-

-

-

-

12,297

12,297

At 30 June 2008

9,646,776

(3,278,481)

-

709,845

12,297

7,090,437

Profit/(Loss) for the year

24

-

(5,609,112)

-

-

-

(5,609,112)

Total Income and Expenditure for the year

-

(5,609,112)

-

-

-

(5,609,112)

Foreign currency translation

24

-

-

42,268

-

-

42,269

Share based payments

24

-

-

-

28,487

-

28,487

Transfer to income statement

24

-

-

-

-

(12,297)

(12,297)

At 30 June 2009

9,646,776

(8,887,593)

42,268

738,332

-

1,539,783

Parent

Employee

Cash flow

Contributed

Accumulated

Equity

hedge

Total

Note

Equity

Losses

reserve

reserve

Equity

A$

A$

A$

A$

A$

At 1 July 2007

6,553,932

(3,605,225)

679,722

-

3,628,429

Profit/(Loss) for the year

24

-

326,744

-

-

326,744

Total Income and Expenditure for the year

-

326,744

-

-

326,744

Share Issue

23

3,199,282

-

-

-

3,199,282

Transaction costs

23

(106,438)

-

-

-

(106,438)

Share based payments

24

-

-

30,123

-

30,123

Net gain on cash flow hedges

24

-

-

-

12,297

12,297

At 30 June 2008

9,646,776

(3,278,481)

709,845

12,297

7,090,437

Profit/(Loss) for the year

24

-

(5,095,294)

-

-

(5,095,294)

Total Income and Expenditure for the year

-

(5,095,294)

-

-

(5,095,294)

Share based payments

24

-

-

28,487

-

28,487

Transfer to income statement

24

-

-

-

(12,297)

(12,297)

At 30 June 2009

9,646,776

(8,373,775)

738,332

-

2,011,333

The above statement of changes in equity should be read in conjunction with the accompanying notes.

Cash flow Statement

For the year ended 30 June 2009

Consolidated

Parent

2009

2008

2009

2008

Note

A$

A$

A$

A$

Cash flows from operating activities

Receipts from customers (inclusive of GST) 

5,201,832

3,688,380

5,201,832

3,688,380

Grants received (inclusive of GST) 

100,787

754,337

100,787

754,337

Payments to suppliers and employees (inclusive of GST)

(5,059,772)

(3,666,404)

(4,571,947)

(3,671,913)

Interest received

106,987

118,682

106,987

118,682

Net cash flows from operating activities

25

349,834

894,995

837,659

889,486

Cash flows from investing activities

Proceeds from sale of plant and equipment 

500

1,586

500

1,586

Purchase of plant and equipment

(195,067)

(140,505)

(192,912)

(140,505)

Purchase of intangibles

(97,235)

(104,553)

(97,235)

(104,553)

Costs incurred on research and development

(2,139,285)

(2,334,396)

(2,139,285)

(2,334,396)

Acquisition of subsidiary

25

-

-

-

(174)

Net cash flows used in investing activities

(2,431,087)

(2,577,868)

(2,428,932)

(2,578,042)

Cash flows from financing activities

Loans to Group

-

-

(472,282)

-

Proceeds from issue of shares

-

3,199,282

-

3,199,282

Transaction costs on issue of shares

-

(106,438)

-

(106,438)

Net cash flows from financing activities

-

3,092,844

(472,282)

3,092,844

Net increase/(decrease) in cash and cash equivalents

(2,081,253)

1,409,971

(2,063,555)

1,404,288

Net foreign exchange differences

(10,828)

(14,152)

(53,636)

(14,152)

Cash and cash equivalents at the beginning of the period

2,771,247

1,375,428

2,765,564

1,375,428

Cash and cash equivalents at end of period

12

679,166

2,771,247

648,373

2,765,564

The above cash flow statement should be read in conjunction with the accompanying notes.

--- ENDS ---

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR CKBKQNBKBNCB
Date   Source Headline
12th May 20267:00 amRNSUS$3.8m Order for Guardian BdMS
6th May 20267:00 amRNSQ3 FY2026 Quarterly KPIs
20th Apr 202612:30 pmRNSHolding(s) in Company
10th Apr 20268:53 amRNSStatement re alleged cyber threat
27th Mar 20267:00 amRNSHalf-year Financial Report
24th Feb 20267:00 amRNS-RPublication of Investor Presentation
18th Feb 20267:00 amRNSTrading Update - H1 FY2026
13th Feb 20267:30 amRNSAppointment of Joint Broker
11th Feb 20267:00 amRNSQ2 FY2026 Quarterly KPIs
13th Jan 202612:00 pmRNS-R3D Cabin Perception Mapping breaks new ground
6th Jan 20267:00 amRNSAgreement
5th Jan 20267:00 amRNSHolding(s) in Company
5th Jan 20267:00 amRNS-R3D Cabin Perception Mapping to be unveiled at CES
2nd Jan 20267:00 amRNS-RSeeing Machines Announces Future Mobility Group
2nd Jan 20267:00 amRNS-RSeeing Machines Announces Future Mobility Group
17th Dec 20257:00 amRNS-RTechnical Paper Series - Intoxication launched
4th Dec 20257:00 amRNS-RSeeing Machines 2025 Guardian Insights Report
27th Nov 20257:00 amRNSResults of AGM
26th Nov 20257:30 amRNSJapanese Auto Award and Extended European Program
12th Nov 20257:05 amRNSQ1 FY2026 Quarterly KPIs
12th Nov 20257:00 amRNSGuardian order from US-based multinational company
6th Nov 20257:05 amRNS-RCollaboration with Magna milestone in China
3rd Nov 20257:00 amRNSBoard Changes
3rd Nov 20257:00 amRNSNotice of Annual General Meeting
30th Oct 20257:00 amRNSLATAM Distributor Orders 1,300 Guardian Units
29th Oct 20257:00 amRNSAdvanced Development Project with Japanese OEM
8th Oct 20257:00 amRNSUS$1.8m expansion order for Guardian BdMS
26th Sep 20257:00 amRNSExpanding Guardian prospects across Europe
25th Sep 20257:00 amRNSFY2025 Results and Annual Financial Report
24th Sep 20257:20 amRNSFirst Guardian contract through Mitsubishi
10th Sep 20257:05 amRNS-RSeeing Machines Launches Impairment Capability
10th Sep 20257:00 amRNSNotice of Results and Presentation
29th Aug 202510:10 amRNSDirector Dealing
21st Aug 20257:00 amRNSFY2025 Trading Update
5th Aug 20257:00 amRNSQ4 FY2025 Quarterly KPIs
30th Jun 20257:00 amRNSMitsubishi Electric Europe Guardian collaboration
27th Jun 20257:00 amRNSUS Guardian Gen 3 trial with Mitsubishi Electric
16th Jun 20258:59 amRNS$1.2 Million Agreement with Global Auto Leader
9th May 20252:31 pmRNSDirector dealing
1st May 20257:00 amRNSQ3 FY2025 Quarterly KPIs
29th Apr 20259:58 amRNSNotification of Major Holdings
8th Apr 20258:53 amRNSHoldings in Company
8th Apr 20257:00 amRNSDirector/PDMR Shareholding
4th Apr 20257:00 amRNSDirector dealing
2nd Apr 202511:00 amRNSLondon presentation for investors and analysts
2nd Apr 20257:00 amRNSDirector dealing
2nd Apr 20257:00 amRNSDirector dealing
1st Apr 202512:00 pmRNS-RSeeing Machines Announces 3D Camera Technology
31st Mar 20257:00 amRNSDirector/PDMR Shareholding
28th Mar 20257:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.